Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differentiation therapy.

R L Paquette1, H P Koeffler

  • 1Division of Health Sciences, University of California, School of Medicine, Los Angeles.

Hematology/Oncology Clinics of North America
|June 1, 1992
PubMed
Summary

Certain compounds, including Vitamin D derivatives and retinoids, can prompt myeloid leukemia cells to mature. These agents are used in treating myelodysplastic syndromes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival.

Oncogenesis·2025
Same author

Targeting the vulnerability to NAD<sup>+</sup> depletion in B-cell acute lymphoblastic leukemia.

Leukemia·2017
Same author

Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma.

Oncogenesis·2017
Same author

Preleukemia: one name, many meanings.

Leukemia·2016
Same author

Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD.

Leukemia·2016
Same author

ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.

Oncogene·2016

Area of Science:

  • Hematology
  • Cell Biology
  • Oncology

Background:

  • Myeloid leukemia involves immature myeloid cells.
  • Cell differentiation is key to myeloid maturation.
  • Therapeutic differentiation offers a treatment strategy.

Purpose of the Study:

  • To identify compounds that induce myeloid cell differentiation.
  • To explore the therapeutic potential of these compounds in myelodysplastic syndromes.

Main Methods:

  • In vitro studies using myeloid leukemia cell lines.
  • Treatment with Vitamin D derivatives, retinoids, interferons, and polar-planar compounds.

Main Results:

  • Demonstrated morphological and functional maturation of myeloid leukemia cells.
  • Identified specific compound classes with differentiation-inducing activity.

Conclusions:

  • Vitamin D derivatives, retinoids, interferons, and polar-planar compounds effectively induce myeloid cell differentiation.
  • These agents represent a viable therapeutic approach for myelodysplastic syndromes.

Related Experiment Videos